Flavivirus NS1 as a pivotal virulence factor and a tractable target for next-generation antivirals, vaccines, and immunodiagnostics
- 18 April 2026
- journal article
- review article
- Published by Elsevier in Current Opinion in Virology
- Vol. 76, 101536
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education - Singapore (T2EP30124-0035)
This publication has 77 references indexed in Scilit:
- Global dengue epidemic worsens with record 14 million cases and 9000 deaths reported in 2024International Journal of Infectious Diseases, 2025
- The ApoA1-mimetic peptide 4F blocks flavivirus NS1-triggered endothelial dysfunction and protects against lethal dengue virus challengeAntiviral Research, 2024
- Structural biology of flavivirus NS1 protein and its antibody complexesAntiviral Research, 2024
- Structural insights into the distinct protective mechanisms of human antibodies targeting ZIKV NS1hLife, 2024
- UCSF ChimeraX : Tools for structure building and analysisProtein Science, 2023
- Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease TropismCell Reports, 2019
- A Global Interactome Map of the Dengue Virus NS1 Identifies Virus Restriction and Dependency Host FactorsCell Reports, 2017
- Crystal structure of the C-terminal fragment of NS1 protein from yellow fever virusScience China Life Sciences, 2017
- Germinal Center B Cell DynamicsImmunity, 2016
- The dengue virus nonstructural-1 protein (NS1) generatesantibodies to common epitopes on human blood clotting,integrin/adhesin proteins and binds to humanendothelial cells: potential implications in haemorrhagic fever pathogenesisArchives of Virology, 1997